Antiviral Peptides Targeting the West Nile Virus Envelope Protein - Wikidata - awgldk - TriplyDB

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

http://www.wikidata.org/entity/Q27478055

about

Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein West Nile Virus: biology, transmission, and human infection Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection Closing the door on flaviviruses: Entry as a target for antiviral drug design Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection IL-10 Signaling Blockade Controls Murine West Nile Virus Infection Progress on the development of therapeutics against West Nile virus Structural optimization and de novo design of dengue virus entry inhibitory peptides Inhibition of influenza A virus infection in vitro by peptides designed in silico Analysis and prediction of highly effective antiviral peptides based on random forests Marine peptides and their anti-infective activities Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes.Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention.A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes.Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Infectivity inhibition by overlapping synthetic peptides derived from the gH/gL heterodimer of herpes simplex virus type 1.A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo.Strategies for the treatment of dengue virus infections: a narrative account.Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.Prediction of antiviral peptides derived from viral fusion proteins potentially active against herpes simplex and influenza A viruses AVPpred: collection and prediction of highly effective antiviral peptides.Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.Peptides as Therapeutic Agents for Dengue Virus.West nile virus neuroinvasive disease.

P2860

Q22570477-28DB60DA-D026-4A32-AD82-329E18D9ADD7 Q24705181-DC323F2B-B2C4-4F2C-89DB-A9CE55068DD7 Q26700124-7AF3A557-DDD2-4D74-95CF-C3D3512FEF14 Q26865618-0BE5D7D3-A334-47D3-B378-1A5DE98B3C1E Q27484983-E03E02C1-1334-47D3-94F0-583881271F11 Q27487953-02143A03-7F95-437E-9232-5DACBD4B1BE4 Q27488337-9E5261CA-695F-4E19-BB06-B7005F126BDE Q27489722-16F87C74-F4AE-4237-8C0C-CF431BDE9E65 Q27489893-B47BBC74-7172-4502-A41C-B75DB3F74940 Q28474595-51BC1CD7-8033-4F44-A354-721E71706ECD Q28534343-EB3952B3-93DA-4A9F-B1F4-56ACFD60F650 Q28535105-E52F70E7-A0EA-4982-B4A1-CF6572530984 Q28651520-489C14DD-A07B-4082-9735-463B9D13B3A1 Q30857727-DE915CD7-18AC-47CC-AEB3-2E55CD9A529C Q34195900-C0A7D766-B80B-4227-9111-5DBB2EF79DF1 Q34864567-096AE00A-57B7-43BB-8008-8796AFBFE172 Q35097106-CD29F3CA-C67B-44D4-A40C-69B7E5DFEA64 Q35542492-657FF487-2B7F-4E26-B690-23862CB6A8B7 Q35739141-AA00209E-5B60-49BA-848F-B2D3242C198C Q35855216-CB927F4C-4A89-4162-A3D8-E30890D44038 Q35860797-A4D5C505-ED78-4347-B744-E8455BE8EB2E Q38260862-2660172E-0C44-4740-A5A1-33C74DE38933 Q38866173-9F6229EC-4E1A-4946-BD72-2199F6C25391 Q38962811-8B971714-226C-47CD-8FDD-78B0018D1E81 Q39051535-70B5E687-6E1D-47D5-8830-223A9550D6B0 Q39769368-E25C1141-A4A7-4E47-91E2-4225A634356A Q40180290-07AB0F4A-6943-41FC-8004-F611111243F2 Q41493353-DE7727BB-7644-4FAF-B226-94E18FA3BAC2 Q42232907-D7A750E9-BD9E-42D9-96D3-2E9A215EDF9F Q42730622-2E11E75D-6884-4C29-8CCC-8C3B278B91F5 Q45323856-ECA89E3D-79A8-4B2D-85F6-E22F60633BE0 Q51163679-84790548-5675-4082-8992-B3FF51E2F984

P2860

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

http://www.wikidata.org/entity/Q27478055

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@ast

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@en

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@nl

type

label

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@ast

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@en

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@nl

prefLabel

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@ast

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@en

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@nl

P1433

Q27478055-B7324B2E-B537-40FE-9CB7-B398DB289F16

P1476

Q27478055-F1EA9060-9102-4746-8334-86856D9BB712

P2093

Q27478055-4714ED6B-A45B-4AAE-9389-09FAE9187FA7

Q27478055-6BF1DDC4-746F-4235-9120-69A6F288748E

Q27478055-8D965BA4-43FB-4B39-849E-1A4C17DD1DD7

Q27478055-911B13BB-A877-4E2C-AC48-B8C421C6B652

Q27478055-98C7A2A0-9714-4CCB-91E0-CC07D7A06161

Q27478055-B6106F8D-82A1-4F94-92A2-F18BA62E6C11

Q27478055-D1269205-D99D-4BDD-A728-A9EA3334E47A

Q27478055-DAACF873-B700-4AF4-B884-9949827952CC

Q27478055-E8895034-72B9-4AFC-8D56-F29BAE66ED41

P2860

Q27478055-122C479A-A991-4890-B3DB-9BC64825E1E0

Q27478055-1B6923A1-7698-4447-A688-A38CB143299F

Q27478055-1D4B1DD7-0F8B-4F32-B2DB-C26A073AA04A

Q27478055-1E5D81CF-A756-4BB0-8B95-DC39EB8D1A64

Q27478055-21BFD9E4-71C6-4903-8196-D94A5D4192C0

Q27478055-253ECB30-D38D-4A51-AEE0-C32B324D8E6C

Q27478055-386A609E-D14E-45D8-BE44-77C74273DCEB

Q27478055-39381658-C766-4139-B2EA-DA85F4388788

Q27478055-3C352BC6-09C6-4E85-BF65-4C67A9AB709F

Q27478055-3DA47D73-592C-4F09-B359-437D3F3BA673

P304

Q27478055-C4A709C4-FE25-41E5-A69F-954491B128CD

P31

Q27478055-3D076BAD-E292-4D3E-AD16-E4C524188692

P3181

Q27478055-862A46F1-EB88-468C-AAB7-721962D63663

P356

Q27478055-60DEA092-A9AB-45AC-84C8-33BF5EF65F05

P433

Q27478055-1B6167D7-26BB-412A-ACB8-B19F6D8AA719

P478

Q27478055-AB6DC649-7FFB-492C-9706-479A5534DC24

P50

Q27478055-1B588F85-8AE3-44B4-B947-7147479A0CDB

Q27478055-85981DA9-E364-4B7B-B318-1EC903CED8FF

P577

Q27478055-634E1FBE-4D42-4DD1-900E-138490BD7DD2

P5875

Q27478055-204EAD5F-5792-4FEA-AD32-0C6E55AE2C9C

P698

Q27478055-78EE99AE-5108-4AEA-8C19-6D4A1121984C

P921

Q27478055-C3055034-6FD6-424B-A418-BD91CD5A96B9

P932

Q27478055-00D45E0B-6803-419F-B2D6-8A948C6DA15A

P3181

P356

P1433

Journal of Virology

P1476

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

@en

P2093

Ashish

http://www.w3.org/2001/XMLSchema#string

Deepti Pradhan

http://www.w3.org/2001/XMLSchema#string

Fengwei Bai

http://www.w3.org/2001/XMLSchema#string

Joanna K Krueger

http://www.w3.org/2001/XMLSchema#string

John F Anderson

http://www.w3.org/2001/XMLSchema#string

Jonathan Cox

http://www.w3.org/2001/XMLSchema#string

Raymond A Koski

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

Terrence Town

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey

Epidemiology and transmission dynamics of West Nile virus disease

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Peptide inhibitors of dengue virus and West Nile virus infectivity

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

HIV-1 gp41 as a target for viral entry inhibition

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

A structural perspective of the flavivirus life cycle

The global emergence/resurgence of arboviral diseases as public health problems

P304

2047-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4760213

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01840-06

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6648539

http://www.w3.org/2001/XMLSchema#string

P698

17151121

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

1797586

http://www.w3.org/2001/XMLSchema#string